Efavirenz and Nevirapine in HIV-1 Infection: Is There a Role for Clinical Pharmacokinetic Monitoring?

By Dahri Karen   Ensom Mary H.H.  

Clinical Pharmacokinetics, Vol. 46, Iss. 2, 2007-01 ,pp. : 109-132

Adis International

Access to resources Recommend Favorite

Nevirapine not recommended for prophylaxis of HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors

By Dailly Eric   Billaud Eric   Reliquet Véronique   Breurec Sébastien   Perré Philippe   Léautez Sophie   Jolliet Pascale   Bourin Michel   Raffi François  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. : 343-348

Springer Publishing Company

Access to resources Recommend Favorite

Nevirapine: A Review of its Use in the Prevention and Treatment of Paediatric HIV Infection

By Bardsley-Elliot A.   Perry C.M.  

Pediatric Drugs, Vol. 2, Iss. 5, 2000-09 ,pp. : 373-407

Adis International

Access to resources Recommend Favorite

Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals

By de Maat M.M.R.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 629-637

Adis International

Access to resources Recommend Favorite